ReviewJournal of pharmacy & bioallied sciences2025
Integrating Superior Hypogastric Plexus Block with Conventional Therapies: Advancements in Chronic Pelvic Pain Management.
Review in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pelvic pain (CPP) is a complex and debilitating condition affecting a significant proportion of individuals, predominantly women. Conventional therapies, including pharmacological and non-pharmacological approaches, often provide limited relief and are associated with significant side effects or patient compliance challenges. Superior hypogastric plexus block (SHPB) has emerged as a promising adjunctive treatment for managing refractory CPP, targeting the nerve pathways responsible for pain transmission from the pelvic organs. This review aims to explore the integration of SHPB with conventional therapies to optimize pain management in CPP, enhancing therapeutic outcomes and improving patient quality of life. A comprehensive review of the literature was conducted, focusing on clinical studies evaluating the efficacy of SHPB in combination with traditional pharmacological treatments (nonsteroidal anti-inflammatory drugs, opioids, antidepressants) and nonpharmacological interventions (physical therapy, cognitive-behavioral therapy).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.